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Abstract
Aminoacidusage inaproteomedependsmostlyon its taxonomy,as it does thecodonusage in transcriptomes. Here,weexplore the
level of variation in the codon usage of a specific amino acid, glutamine, in relation to the number of consecutive glutamine residues.
We show that CAG triplets are consistently more abundant in short glutamine homorepeats (polyQ, four to eight residues) than in
shorter glutamine stretches (one to three residues), leading to the evolutionary growth of the repeat region in a CAG-dependent
manner. The length of orthologous polyQ regions is mostly stable in primates, particularly the short ones. Interestingly, given a short
polyQ the CAG usage is higher in unstable-in-length orthologous polyQ regions. This indicates that CAG triplets produce the
necessary instability for a glutamine stretch to grow. Proteins related to polyQ-associated diseases behave in a more extreme
way, with longer glutamine stretches in human and evolutionarily closer nonhuman primates, and an overall higher CAG usage.
In the light of our results, we suggest an evolutionary model to explain the glutamine codon usage in polyQ regions.
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Introduction
Homorepeats are defined as runs of the same amino acid in a
protein sequence. Given the repeated amino acid X, its homo-
repeat is known as polyX, X-AAR (amino acid repeat), or
X-homopeptide (Zhou et al. 2011). The prevalence and func-
tions of a polyX vary in proteomes depending on known (nat-
ural selection, taxonomy, length, GC content) (Faux et al.
2005; Mularoni et al. 2010; Zhou et al. 2011; Mier et al.
2017) and unknown factors (e.g., the case of poly-
asparagines in the amoeba Dictyostelium discoideum and
the protozoan Plasmodium falciparum) (Eichinger et al.
2005; Muralidharan and Goldberg 2013).
From a purely anthropocentric point of view, the most
interesting homorepeats are the poly-glutamines (polyQ).
Besides being one of the most prevalent homorepeats in
eukaryotes (Faux et al. 2005; Mier et al. 2017), abnormal
expansion of glutamine tracts (via CAG trinucleotide
repeats) are associated with at least nine inherited neuro-
degenerative diseases (Fan et al. 2014; Den Dunnen 2017).
None of these diseases are neither curable nor effectively
treatable so far, despite the many attempts to fathom the
role of the extended polyQ in the progression of the dis-
order and the development of potential therapeutic
approaches (Hughes and Olson 2001; Robertson and
Bottomley 2010; Margulis et al. 2013; Fan et al. 2014;
Takeuchi et al. 2014; Takeuchi and Nagai 2017).
Intrinsically, the presence of CAG and other CNG repeats
affects mRNA stability and structure (Broda et al. 2005), and
their abnormal expansion in disease can influence splicing
(Neueder et al. 2017). On the other hand, at the protein level
the length of a polyQ region correlates with its propensity to
aggregate (Barton et al. 2007), and is a critical determinant of
age-of-disease onset (Nagai et al. 2000). These facts underline
the importance of a better comprehension of the evolutionary
perspective of the growth of glutamine tracts and its codon
usage.
Although polyQ is a common accepted term for stretches
of consecutive glutamine residues, thresholds of a minimum
of four out of five (UniProt, http://www.uniprot.org/help/
compbias; last accessed February 26, 2018), four out of six
(Mier and Andrade-Navarro 2017), five (Alba and Guigo
2004; Jorda and Kajava 2010; Chavali et al. 2017), six
(Lobanov and Galzitskaya 2012), and eight out of ten
(Schaefer et al. 2012; Mier and Andrade-Navarro 2016) glu-
tamine residues have been used so far to refer to polyQ
regions. Although it has been demonstrated that for human
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and metazoan proteomes a stretch of five consecutive gluta-
mines is not a random feature and thus can be considered a
polyQ (Lobanov et al. 2016), we showed in a previous re-
search (Totzeck et al. 2017) that a protein sequence with a
minimum of four glutamines in a window of six amino acids
already possesses characteristic features of a polyQ region. To
study the maximum number of glutamine stretches but also
to account for the functional and structural implications of a
polyQ, we consider that: a glutamine stretch may be consid-
ered for Q 1, a polyQ region may be considered for Q 4, a
short polyQ has a defined length of 4Q 8, and a long
polyQ is Q 9 residues long. We note that these thresholds
are likely specific to polyQ and might not apply to other
homorepeats, as the properties of homorepeats are highly
influenced by the repeated residue type (Bernacki and
Murphy 2011; Lu and Murphy 2015).
Glutamine is coded by synonymous codons CAA and CAG.
Codon usage biases are organism- or taxa-specific and are
affected by natural selection (Lynn et al. 2002; Athey et al.
2017). Codon optimality derived from these biases is a major
determinant of mRNA stability (Presnyak et al. 2015) and
controls mRNA translation (Saikia et al. 2016). In primates,
CAG is roughly three times more frequent than CAA (35.28
and 13.66 per 1,000 codons, respectively) (Athey et al. 2017),
driving the glutamines to be coded by a 72.09% CAG
(71.85% CAG in human). These numbers do not consider
any additional feature of the coded glutamine, like if it is
influenced by the presence of adjacent glutamine residues.
In this work, we characterize the length-dependent codon
usage of glutamine in glutamine stretches from complete pro-
teomes of diverse taxonomic lineages. Focusing on orthologous
Q stretches from primates, their length differences and the
codon usage of stable- versus unstable-in-length stretches are
assessed. We also show how glutamine stretches in proteins
related to polyQ-associated diseases deviate from the expected
proteome-wide codon usage, and propose an evolutionary
model to explain the glutamine codon usage in polyQ regions.
Materials and Methods
Data Retrieval
We downloadedall codingandpeptidesequences fromprotein
coding genes from the human data set GRCh38.p10 using
Ensembl/Biomart version90 (Yatesetal. 2016). Similar informa-
tionwasretrievedforallnonhumanprimates forwhichEnsembl
provides informationaboutorthology relationshipswithhuman
sequences: Pan troglodytes (ptr, CHIMP2.1.4), Gorilla gorilla
gorilla (ggo, gorGor3.1), Pongo abelii (pab, PPYG2),
Nomascus leucogenys (nle, Nleu1.0), Macaca mulatta (mmul,
Mmul8.0.1),Chlorocebus sabaeus (csa, ChlSab1.1), Papio anu-
bis (pan, PanAnu2.0), Callithrix jacchus (cja, C_jacchus3.2.1),
Carlito syrichta (csy, tarSyr1), Otolemur garnettii (oga,
OtoGar3), and Microcebus murinus (mmur, Mmur2.0).
The downloaded data were complemented with coding
and peptide sequences from protein coding genes of model
organisms from different taxonomic groups available in
Ensembl/Biomart version 90: Mus musculus (mmu,
GRCm38.p5), Rattus norvegicus (rno, Rnor6.0), Sus scrofa
(ssc, Sscrofa11.1), Monodelphis domestica (mdo,
monDom5), Gallus gallus (gga, Gallus_gallus-5.0),
Taeniopygia guttata (tgu, taeGut3.2.4), Xenopus tropicalis
(xtr, JGI 4.2), Latimeria chalumnae (lch, LatCha1), Danio rerio
(dre, GRCz10), Takifugu rubripes (tru, FUGU 4.0), Ciona intes-
tinalis (cin, KH), Drosophila melanogaster (dme, BDGP6),
Caenorhabditis elegans (cel, WBcel235), and Saccharomyces
cerevisiae (sce, R64-1-1).
We considered the downloaded data sets from Ensembl as
reference, and did not account neither for intraspecies poly-
morphicvariationnor for thequalityof thegenomeassemblies.
Glutamine Stretches and Codon Usage
We calculated the glutamine codon usage in all the retrieved
data sets from Ensembl by counting the number of CAA and
CAG triplets in pure Q stretches. The length of a Q stretch was
taken as the number of consecutive glutamines, in a non-
nested way (e.g., “QQQQ” was considered to be of length
four glutamines, and not one time “QQQQ”, two times
“QQ”, and four times “Q”).
The orthology information obtained from Ensembl was in-
tegrated togenerate setsoforthologsperhumanprotein.We
took into account only the sets in which all nonhuman pri-
mates had at least one ortholog to the human protein. From
them, we considered solely the sets in which at least one se-
quence had at least one region with four or more consecutive
glutamines (supplementary file 1, Supplementary Material
online). PolyQ regions from proteins with more than one glu-
tamine stretch were analyzed independently. All the regions
meeting thisconditionweremanually verified,andwerecom-
pared with the different aligned orthologous sequences.
To study the length of the Q stretches in the orthologs, we
aligned them in UGENE v1.9.8 (Okonechnikov et al. 2012)
using the T-Coffee algorithm with default parameters. To de-
termine the length of a Q stretch, we counted the number of
consecutive glutamines. An exception was made when two
different Q stretches should have been considered in one se-
quence, and only one in an aligned orthologous region (e.g.,
“QQQQPQQQQ” in one protein aligned with
“QQQQQQQQQ”). In that case, we counted the total num-
ber of glutamines in the aligned region, and not just the pure
Q stretches (e.g., “QQQQPQQQQ” is considered to be of
length eight glutamines and “QQQQQQQQQ” of nine gluta-
mines); we did not analyze further the identity of the different
amino acids present within the polyQ region. To study the
glutamine codon usage in the orthologs, we followed the
same procedure, counting the number of CAA and CAG
triplets forming the Q stretches. In this case, we used the
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standalone version of TranslatorX (Abascal et al. 2010), with
default parameters, to easily visualize the nucleotide align-
ments separated by codons.
The length of a Q stretch was considered to be stable if at
least half of the orthologs had the same length; otherwise, it
was considered unstable. In that case, we took as length of
the unstable-in-length Q stretch the most frequent length
among the orthologs. Given the case of two or more most
frequent lengths, we took as the unstable length the most
frequent one closest in evolution to human.
Reported P values are the result of a nonparametric Mann–
Whitney U statistical test.
Phylogenetic Relationships between Species
To assess the pairwise divergence time for each species and
human, we obtained the estimated divergence time in million
years given by the TimeTree database (Kumar et al. 2017). We
used the phyloT tool version 2017.7 (http://phylot.biobyte.de/;
last accessed February 26, 2018) to generate a phylogenetic
tree to relate the organisms based on NCBI taxonomy.
Proteins Related to polyQ-Associated Diseases
The amino acidic and nucleotidic sequences from the nine
human proteins related to polyQ-associated diseases (Fan
et al. 2014) (supplementary file 2, Supplementary Material
online) were extracted from the downloaded data sets.
Similarly, the orthologous sequences from the nonhuman pri-
mates were used. To complement the information about
orthologs to those nine human proteins that were not defined
by Ensembl, we conducted an additional procedure. We per-
formed a BLAST search using the human protein as query
versus the proteomes of the nonhuman primates with no
defined ortholog (one search per human protein), using de-
fault parameters and low complexity filter off. As our only
purpose here is to evaluate the length and codon usage of
the one glutamine stretch associated to the disease, we con-
sidered a sequence as orthologous to the human query if their
alignment covered the coordinates of the human disease-
associated Q stretch. Fragments of orthologs not containing
that Q stretch were thus not considered.
We followed the strategy explained above to evaluate the
Q stretch length and codon usage of the full set of available
orthologs to the nine human proteins related to polyQ-
associated diseases.
Results
Glutamine Codon Usage Is Enriched in CAG Triplets in
Longer Q Stretches
Amino acid codon usage has varied throughout evolution,
and depend mostly on taxonomy. Here, we want to assess
whether it is also influenced by the context of the surrounding
codons. Focusing on the amino acid glutamine, Q, we calcu-
lated the frequency of glutamine stretches of different lengths
in a set of 26 organisms representing major taxonomic
groups, from the yeast Saccharomyces cerevisiae to the hu-
man proteome. For each stretch of consecutive glutamines in
a proteome, we computed its length and the number of both
CAA and CAG codons coding for the stretch (see Methods for
details).
Glutamine stretches of short length are present in approx-
imately similar numbers in all proteomes, and their proportion
is extremely stable in primates (fig. 1a). There are in average
more than ten “Q”, around one “QQ” and 0.1 “QQQ” per
protein. It has been reported before that glutamines are
coded by a 72% CAG in human (Athey et al. 2017); our
results confirm it (fig. 1b, hsa), but solely in short glutamine
stretches (1–3 Q). Glutamine stretches longer than three glu-
tamines are coded by a higher CAG percentage. The larger
proportion of 1–3 glutamine stretches (fig. 1a) bias the direct
calculation of the glutamine codon usage. More distant-in-
evolution species behave differently, with lower values of
CAG percentages in 4–8 Q than in 1–3 Q in the zebrafish
Danio rerio (dre) and the tunicate Ciona intestinalis (cin)
(fig. 1b). The contrast of the percentage of CAG codons in
4–8 Q stretches versus in 1–3 Q stretches, that is, short polyQ
and not polyQ, show a high correlation between these values
when plotting the results for the 26 species (fig. 1c). Most of
the species cluster in values of 70% CAG for 1–3 Q stretches
and 80% CAG for 4–8 stretches, but S. cerevisiae (sce),
Caenorhabditis elegans (cel), and C. intestinalis (cin). These
three species are distant to human in evolution (676–
1,105 Myr), which suggests the length-dependent glutamine
codon usage was fixed after their speciation event.
Human and the rest of the nonhuman primates show sim-
ilar proportions of glutamine stretches per protein, and also of
the length-dependent CAG percentage, as described earlier.
When itemizing the glutamine lengths from one to eight
glutamines, and more than eight glutamines (fig. 1d), the
triplet CAG is used in primates preferably in small polyQ
(from a length of 1–3 to 4–8), whereas it is not abundant in
grown homorepeats (>8 Q), for which positive selection for
CAG codons might disappear. The trend in the CAG percent-
age values is clear, and show two well-defined groups of
values (1–3 Q and>3 Q, P¼ 2.2E-16) consistent with our
initial definition of what should be considered a polyQ.
PolyQ Regions in Primates Are of Similar Length
No proteome-wide set of one-to-one orthologous sequences
is available for a set of model organisms including human and
other nonhuman primates. We built it by focusing on the set
of primates studied in the previous section with information
provided by Ensembl (see Methods for details); we used sets
of orthologs in which all proteomes had at least one ortholog.
A total of 8539 sets of orthologous sequences was initially
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FIG. 1.—Characterization of glutamine stretches in complete proteomes. (a) Number of glutamine stretches per number of proteins per proteome,
depending on the stretch length. (b) Percentage of CAG triplets in glutamine stretches per proteome, depending on the stretch length. (c) Percentage of
CAG triplets in glutamine stretches of lengths 4–8 compared with lengths 1–3; the result for each proteome is colored depending on the pairwise divergence
time with human. The discontinuous line represents x¼ y values. (d) Overall CAG percentages in primates in glutamine stretches of varying lengths.
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obtained and then filtered to work only with those in which at
least one protein from any of the organisms had at least one
polyQ of length four or more, which resulted in 347 sets.
From these, we identified 461 independent orthologous
regions.
We counted the maximum number of consecutive gluta-
mines in all the orthologous independent regions within the
described data set, to account for both already-formed and
for emerging/fading polyQ regions. This procedure allows us
to characterize the length of a Q stretch in several points in
evolution. As we are working with the full set of available
completely sequenced primates, we are able to describe the
evolutive drift of glutamine stretches in the last 74 million
years in a comprehensive way.
For a given organism, we took all of its Q stretches as
reference, and calculated the difference between their length
and that of the rest of its orthologous regions. We repeated
the procedure with the 12 primates, and split the results
depending on the length of the reference Q stretch: 0–3
glutamines, 4–8 glutamines, and more than 8 glutamines
(fig. 2). Both short Q stretches and polyQ regions (fig. 2a
and b, respectively) show a general length similarity in all
the species, with a very narrow length difference, especially
in short polyQ. Short Q stretches are present in the results
because at least one of its orthologous regions contain a
polyQ, and thus logically they are generally either similar in
length or shorter, meaning that either a few of the ortholo-
gous regions are a polyQ, or many of them, respectively. Short
polyQ regions appear to be mostly stable-in-length. On the
other hand, long polyQ regions are more unstable-in-length,
although equally dissimilar in all organisms (fig. 2c).
Glutamine homorepeats are then not significantly longer in
human than in the rest of the nonhuman primates.
Most of the 461 orthologous polyQ regions are encoded
by pure CAG codon stretches when short (fig. 3a) and mixed
with CAA codons when long (fig. 3b). There are almost no
CAA pure regions coding for a polyQ stretch (fig. 3d), and
interruptions of different codons are also not frequent
(fig. 3c). Finally, we calculated the longest run of consecutive
CAG codons, and similarly of CAA codons, in stretches
encoded by more than one different triplet. Consecutive
CAA codon runs are always shorter than CAG consecutive
stretches (fig. 3e and f). Both results hint at the use of CAA
codons to disrupt long consecutive CAG stretches.
Glutamine Codon Usage Is Enriched in CAG Triplets in
Shorter Unstable-in-Length polyQ
The length stability of glutamine stretches was already briefly
referred to in the previous section, by comparing the overall
length differences in the full set of 461 independent ortholo-
gous regions. However, a one-by-one study of these regions is
needed to assess their length-dependent stability and codon
usage. We will not focus on polyQ growth or decrease, but in
the stability of their length in the available data set. Both
length growth and decrease would be influenced by the pro-
teome taken as reference; however, the depiction of the
length stability of glutamine stretches among primates is a
property that takes into account all proteomes considered.
We considered a glutamine stretch to be stable-in-length if
it had the same length in at least half of the orthologous
regions. In that case, the stretch is labelled as stable and its
length is taken as the one of the majority of them. Were the
region unstable-in-length, its length would be taken as the
most frequent among the orthologs (see Methods for details).
As previously described (fig. 2), shorter Q stretches are more
stable-in-length than longer ones (fig. 4). Stretches with more
than ten glutamines (28/461 stretches) are rarely stable-in-
length (21% of them). On the other hand, stretches of four
consecutive glutamines (178/461 stretches) are almost always
stable-in-length (97%). Results suggest that short polyQ ap-
pear to be generally held back within a controlled length
range. They are most probably long enough to be functional,
while not in risk of an unexpected expansion that could lead
to instability and disease.
Separate codon usage calculations in stable-in-length/
unstable-in-length and short/long polyQ regions show that
CAG is more frequent in short and unstable-in-length polyQ
(“4-8U”) in all studied primates (fig. 5, P¼ 8.94E-08). This
result suggests that CAG codons destabilize the
glutamine stretch, probably assisting in the growth of the
region.
A Closer Look into the Proteins Related to polyQ-
Associated Diseases
There are nine human proteins associated with diseases pro-
duced by the abnormal elongation of their polyQ regions.
Following a similar procedure as the explained before, we
checked both the polyQ length and glutamine codon usage
in these proteins in 12 primates. The proteins in study are
characterized for being pathological when surpassing an
anomalous polyQ length threshold, specific for each protein.
For example, the normal length of the glutamine repeat in
human protein Huntingtin (EnsemblID: ENSP00000347184) is
described to be 6-35, and in its pathological version 36-121
(Fan et al. 2014). It is important to notice that in this study we
refer to the length of the polyQ region in the sequence
obtained from the Ensembl database, which we take as ref-
erence; for Huntingtin, the sequence version present in
Ensembl is 21 glutamines long.
All the proteins related to polyQ-associated diseases con-
tain one polyQ region, but the androgen receptor (EnsemblID:
ENSP00000363822), which contains three, with 23, 6, and 5
glutamines (in coordinates 58–80, 86–91, and 195–199, re-
spectively). As the pathological stretch is the first of them, for
the purpose of this work, we did not considered the second
and the third regions.
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Not every analyzed organism contains all of these nine
proteins. The protein absences may be due to problems in
the orthology mapping given by Ensembl, an erroneous ge-
nome sequencing or protein-coding gene annotation, or sim-
ply due to a gene loss event. We complemented the Ensembl
orthology mapping with a manual strategy based on BLAST
searches in the 12 proteomes to fill as much as possible the
sets of orthologs for each protein (see Methods for details).
The overall length of the glutamine stretches in these pro-
teins show that the human ones are generally longer (fig. 6, in
blue); in fact, in seven out of nine sets of orthologous proteins,
the human polyQ region is the longest one (not in Ataxin-2
and Ataxin-3). Nonhuman primates evolutionarily closer to
human also have longer polyQ regions than more distant spe-
cies. This is a deviation from the expected results: we have
showed before that polyQ regions in primates are generally of
similar length (fig. 2).
The overall proportion of CAG codons in those regions is
unexpectedly high, with a mean value of >90% CAG in al-
most all species (fig. 6, in red). The CAG codon usage when
computing all polyQ regions with more than eight glutamines
was calculated to be between 75% and 80% for all primates
(fig. 5). The extreme CAG codon presence in the polyQ
regions of proteins related to polyQ-associated diseases may
produce an instability that boosts the CAG-dependent polyQ
growth in evolution, explaining the growth pattern of the
polyQ regions in these proteins from evolutionarily distant
nonhuman primates to human (supplementary fig. 1,
Supplementary Material online, P value¼ 0.007). The differ-
ences at the level of nucleotides (higher CAG triplet propor-
tion than the background) and amino acids (longer glutamine
stretches in human and evolutionarily closer nonhuman pri-
mates) may explain the association of these nine proteins with
human diseases.
Discussion
This work presents a comprehensive evolutionary characteri-
zation of homoglutamine repeats in both amino acidic and
nucleotidic contexts. We have showed that for all studied
species the glutamine codon usage depends on the number
of consecutive glutamines in a stretch, being in most of the
species enriched in CAG triplets in longer Q stretches (fig. 1).
Primates present a direct correlation between the number of
consecutive glutamines in a stretch and the percentage of
CAG triplets coding them, covering glutamine stretches
with lengths 1–3 and short polyQ with lengths 4–8. Once
the polyQ region is established and long enough, the pres-
ence of CAG is not required anymore. Our results suggest the
greater importance of CAG triplets in generating the polyQ
region than in elongating it once it reaches a certain length
threshold. This result is supported by the fact that orthologous
FIG. 2.—Length differences of glutamine stretches between primates. Length differences from the reference glutamine stretch to the rest of the
orthologous glutamine stretches, when the length of the reference stretch is (a) 0–3, (b) 4–8, and (c) >8.
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short unstable-in-length polyQ regions in primates are
enriched in CAG (fig. 5, data labels “4-8U”).
Orthologous glutamine stretches in primates are generally
of a similar length (fig. 2). The length range of orthologous
regions to stretches of length 4–8 is very narrow, which is
confirmed by the greater length stability of shorter glutamine
stretches (fig. 4). In the same way, longer glutamine stretches
are more unstable-in-length, but they are not significantly
longer in any species. Contravening this result, polyQ regions
of proteins related to polyQ-associated diseases are unexpect-
edly longer in human and evolutionarily closer nonhuman
primates (fig. 6). They also deviate from the proteome-wide
codon usage of glutamine stretches, showing an overall
higher CAG proportion in almost all species.
CAA codons serve as disruptors of long pure CAG stretches
(fig. 3), which may be selected for to avoid the uncontrollable
growth of these regions produced by CAG expansion through
slippage-related mechanisms (Kraus-Perrotta and Lagalwar
2016;Ciesiolkaetal.2017).ThesmalleramountofCAAtriplets
encoding for polyQ regions associated to polyQ diseases sug-
gests a role for CAA codons as phenotype modulators. Even
though the frequency of codons different to CAA interrupting
consecutive CAG stretches is low, is has been previously
reported a role of these interruptions evading homologous
DNA recombination (Barik 2017), slowing the aggregation
rates of polyQ regions, decreasing fiber formation rates, in-
creasing oligomer stability (Menon et al. 2013), and preventing
CAG expansion (Ciesiolka et al. 2017). Whether the
FIG. 3.—Codon purity of glutamine stretches in primates. Percentage of glutamine stretches per length encoded by (a) only CAG codons, (b) a mix of
CAG and CAA codons, (c) a mix of CAG, CAA, and other interrupting codons, and (d) only CAA codons. Considering only glutamine stretches encoded by
more than one different triplet, maximum number of consecutive (e) CAG, and (f) CAA per length.
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phenotypic outcome of an interruption in a long CAG stretch
produced by a CAA (silent mutation) or by another codon (mis-
sense mutation) is different remains to be deciphered.
Our interest in the proteins related to polyQ-associated
diseases is anthropocentric, as they are associated with neu-
rological diseases described in human; there are probably
more proteins in nonhuman primates associated with neuro-
degenerative diseases in them which we do not know of be-
cause of their nonpathogenicity in human.
To suggest an evolutionary model to explain the glutamine
codon usage in polyQ regions in primates, we point to the
following observations. First, the percentage of CAG triplets
coding for glutamine stretches depends on the number of
consecutive glutamines (fig. 1d): lower percentages for 1–3
Q, higher percentages for 4–8 Q, and medium percentages
for>8 Q. Second, polyQ length is generally stable across
orthologs (fig. 2). Third, shorter polyQ are more stable-in-
length than longer ones (fig. 4). Fourth, CAG codons are as-
sociated with length instability (fig. 5, “4-8S” vs “4-8U”).
Fifth, much higher percentages of CAG than expected for
their length are present in polyQ regions of proteins related
to polyQ-associated diseases (fig. 6 “Overall %CAG” vs
fig. 1d “>8”), and they present an overall polyQ length lon-
ger in human and evolutionary-related nonhuman primates
and shorter in species more distant in evolution (fig. 6). We
propose then that the observations summarized above collec-
tively suggest the following evolutionary model for polyQ in
primates: 1) CAG are positively selected in evolution to gen-
erate a short polyQ region from a short glutamine stretch; 2) a
short polyQ region is probably long enough to be functional,
and thus their growth is no longer selected; 3) as a mecha-
nism to stop longer polyQ to keep growing and to reduce
instability, CAG triplets are either actively counter selected or
in neutral evolution; 4) longer polyQ regions escaping this
blockage may grow uncontrollably and be involved in the
development of polyQ-associated diseases.
The validity of the presented model needs to be tested
in vivo. Even if the model is thought to explain the glutamine
codon usage in polyQ regions in primates, a more-distant
species with a shorter lifespan could be used to test our hy-
pothesis. For example, by integrating in its genome polyQ
tracts with various CAG percentages, and checking in succes-
sive generations if the glutamine stretches grow in a CAG-
dependent way. The yeast S. cerevisiae has already been used
to express fragments of Huntingtin with polyQ expansions to
study polyglutamine toxicity (Krobitsch and Lindquist 2000;
FIG. 4.—Length-stability of glutamine stretches. Percentage of orthol-
ogous glutamine stretch regions with a stable length in at least half of the
orthologs.
FIG. 5.—Glutamine codon usage in stable- versus unstable-in-length polyQ. Codon usage calculated in stable-in-length (S) and unstable-in-length (U),
short (4–8 Q), and long (>8 Q) polyQ stretches, in 12 primates.
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Duennwald et al. 2006), therefore we propose it as a potential
model organism to prove our model. Furthermore, future
gene therapies may induce point mutations in polyQ regions
to transform CAG codons into CAAs, which could stop ab-
normal CAG-mediated expansions of glutamine tracts.
With this work, we hope to raise awareness to the useful-
ness of studying homorepeat evolution. Gathering informa-
tion from a data set of complete proteomes, we could show
that, while in primates polyglutamines are rather stable-in-
length, they evolve in a CAG-dependent manner. Further
efforts should be made to research the evolution of other
homorepeats, taking advantage of the growing collection of
complete proteomes available in public databases.
Supplementary Material
Supplementary data are available at Genome Biology and
Evolution online.
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FIG. 6.—PolyQ lengths and glutamine codon usage in proteins related to polyQ-expansion diseases. Divergence time for each organism and human is
measured in million years (Myr). The tree on top relates the species based on their NCBI taxonomy. Each protein is appended with its related disease. The
overall Q lengths (in blue) and CAG percentage prevalence (in red) plots take into account the results per species of the nine proteins shown above.
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